Drug Search Results
More Filters [+]

Oxfendazole

Alternative Names: oxfendazole
Latest Update: 2024-08-22
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Czech | Norway | Pakistan

Approved Indications: None

Known Adverse Events: None

Company: Johns Hopkins Bloomberg School of Public Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Oxfendazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Taeniasis|Neurocysticercosis

Phase 2: Communicable Diseases|Fascioliasis|Trichuriasis

Phase 1: Neurocysticercosis|Filariasis|Healthy Volunteers|Taeniasis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT06565507

P3

Not yet recruiting

Taeniasis|Neurocysticercosis

2028-03-30

SIDISI 201221

P2

Not yet recruiting

Fascioliasis

2028-03-01

OXF2 v3.21

P2

Not yet recruiting

Communicable Diseases|Trichuriasis

2026-07-01

HHSN272201300020I

P2

Not yet recruiting

Trichuriasis

2025-10-01

Recent News Events